Related Experiment Videos
Cellular telephones and cancer: how should science respond?
Journal of the National Cancer Institute
|February 7, 2001
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Abnormal P-wave terminal force in lead V1 is associated with low left atrial appendage ejection velocity.
Journal of electrocardiology·2021
Cutaneous paraneoplastic syndrome associated with anal squamous cell carcinoma: a rare presentation of an uncommon cancer.
Current oncology (Toronto, Ont.)·2020
Anti-PD-1/L1-associated immune-related adverse events as harbinger of favorable clinical outcome: systematic review and meta-analysis.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2020
Timing of mental disorders in relation to cancer-specific mortality in cancer patients.
Journal of the National Cancer Institute·2026
Addressing the impact of tobacco and alcohol use on cancer-related health outcomes.
Journal of the National Cancer Institute·2026
Epigenetic aging of colorectal mucosa in cancer development.
Journal of the National Cancer Institute·2026
Randomized trial of adjuvant 5-FU-platinum vs paclitaxel-platinum for high-risk penile cancer.
Journal of the National Cancer Institute·2026
Evaluating longitudinal toxicity and adverse event in cetuximab-treated metastatic colorectal cancer: a pooled analysis from 1,302 patients in ARCAD database.
Journal of the National Cancer Institute·2026
Microenvironment-adaptive drug delivery systems for ulcerative colitis: from pathological constraints to rational design.
Expert opinion on drug delivery·2026
Influence of Exosomes on Tumorigenic Behavior in Triple-Negative Breast Cancer Cells through STAT3 Inhibition in Autophagy.
Asian Pacific journal of cancer prevention : APJCP·2026
Brain cannabinoid CB1 receptor signaling modulates reward responses and inhibitory control in humans.
Imaging neuroscience (Cambridge, Mass.)·2026
Recent advancement in inflammatory biomarkers for cervical cancer diagnosis and therapy.
Frontiers in oncology·2026